Form 8-K NATUS MEDICAL INC For: Sep 22
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 22, 2016
Natus Medical Incorporated
(Exact name of registrant as specified in its charter)
Delaware | 000-33001 | 77-0154833 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||
6701 Koll Center Parkway Suite 120 Pleasanton, CA 94566
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (925) 223-6700
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On September 22, 2016, Natus Medical Incorporated (the "Company") issued a press release announcing the appointment of Barbara R. Paul, M.D. as a member of its Board of Directors.
As a non-employee director, Dr. Paul's compensation consists of a grant of 3,360 Restricted Stock Units per the Company's 2011 Stock Award Plan. The award will vest on September 21, 2017. Dr. Paul will also receive cash compensation of $45,000 pursuant to the Company's board compensation plan.
Item 9.01. | Financial Statements and Exhibits |
(d) Exhibits.
Exhibit No. | Description | |
99.1 | Press release dated September 22, 2016 announcing the appointment of Barbara R. Paul, M.D. as a member of the Board of Directors. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NATUS MEDICAL INCORPORATED | ||||||
Date: September 22, 2016 | By: | /s/ Jonathan A. Kennedy | ||||
Jonathan A. Kennedy | ||||||
Senior Vice President Finance & Chief Financial Officer | ||||||
Exhibit Index
Exhibit No. | Description | |
99.1 | Press release dated September 22, 2016 announcing the appointment of Barbara R. Paul, M.D. as a member of the Board of Directors. | |
Natus Medical Announces Appointment of Barbara R. Paul, M.D. to its Board of Directors
PLEASANTON, Calif. (September 22, 2016) - Natus Medical Incorporated (NASDAQ: BABY) today announced the appointment of Barbara R. Paul, M.D. to its board of directors.
"We are pleased to have Dr. Paul join the Natus Board of Directors," said Robert Gunst, chairman of Natus' board of directors. "Dr. Paul's significant medical and regulatory experience will complement the expertise of our current Board members."
Dr. Paul currently sits on the board of Quorum Health Corporation, an operator and manager of 38 general acute care hospitals and outpatient services. She served as Senior Vice President & Chief Medical Officer at Community Health Systems (CHS) from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.). Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin - Madison and earned her medical degree from Stanford University School of Medicine.
"We are excited to have Dr. Paul join the Natus board of directors," said Jim Hawkins, President and Chief Executive Officer of the Company. "Dr. Paul's background in patient care and at CMS will bring a unique perspective to our board and be invaluable as we grow."
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT:
Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President and Chief Financial Officer
(925) 223-6700
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SHCR INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation – SHCR
- Avangrid Schedules First Quarter 2024 Earnings
- CSG Sends Letter to Senator J.D. Vance Addressing His Concerns Regarding Planned Acquisition of Vista Outdoor’s Sporting Products Business, The Kinetic Group
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
